相关实验视频
Updated: Jul 17, 2025
12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
10.6K
树树皮提取物:表皮溶解中的一篇评论 牛头
1Springer Nature, Mairangi Bay, Private Bag 65901, Auckland, 0754, New Zealand. demail@springer.com.
Drugs
|September 2, 2023
概括
树树皮提取物 (Filsuvez) 是一种新的局部凝,有效治疗表皮溶解牛 (EB) 患者的部分厚度伤口. EASE试验显示了显著的伤口关闭率和持续的好处,具有良好的耐受性.
科学领域:
- 皮肤病学 皮肤病学
- 伤口愈合 治愈 伤口愈合
- 罕见疾病 罕见疾病
背景情况:
- 牛皮表皮溶解 (EB) 是一组罕见的遗传性疾病,其特点是皮肤脆弱,容易出现水泡和伤口.
- 目前EB相关伤口的治疗选择有限,需要新的治疗方法.
研究的目的:
- 评估白树皮提取物 (Filsuvez) 的疗效和安全性,用于治疗缩性和结节性表皮溶解病患者的部分厚度伤口.
- 评估木树皮提取物在EB患者的长期临床益处和耐受性.
主要方法:
- 一个关键的,双盲的,随机的,车辆控制的,III期EASE试验在6个月及以上的EB患者中进行.
- 患者接受了树皮提取物 (Filsuvez) 或控制凝,主要终点是患者在45天内实现首次完全关伤口的比例.
主要成果:
- 主要终点得到满足,表明与对照凝相比,患者中使用木树皮提取物实现完整伤口关闭的比例显著更高.
- 树皮提取物治疗也显示了伤口负担和相关症状的改善.
- 在24个月的开放标签延长期内,治疗的好处保持不变,治疗耐受性良好.
结论:
- 树树皮提取物 (Filsuvez) 是一种有效和新兴的治疗方法,用于部分厚度的伤口在患有缩和结节性EB的患者.
- 该疗法提供了持续的临床益处和良好的耐受性概况,代表了EB伤口护理的重大进步.
相关概念视频
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
01:12Renewal of Skin Epidermal Stem Cells
2.5K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.5K
01:02Long-patch Base Excision Repair
7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K